Vanguard Group Inc Neurocrine Biosciences Inc Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 10,119,641 shares of NBIX stock, worth $1.1 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,119,641
Previous 9,996,960 1.23%
Holding current value
$1.1 Billion
Previous $1.15 Billion 20.02%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$111.62 - $139.44 $13.7 Million - $17.1 Million
122,681 Added 1.23%
10,119,641 $1.38 Billion
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $6.82 Million - $9.11 Million
-59,486 Reduced 0.59%
9,996,960 $1.15 Billion
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $16.4 Million - $18 Million
125,520 Added 1.26%
10,056,446 $1.38 Billion
Q1 2024

May 10, 2024
BUY
$130.4 - $143.74 $28.8 Million - $31.7 Million
220,598 Added 2.27%
9,930,926 $1.37 Billion
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $16 Million - $20 Million
150,485 Added 1.57%
9,710,328 $1.28 Billion
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $1.02 Million - $1.27 Million
-10,875 Reduced 0.11%
9,559,843 $1.08 Billion
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $2.4 Million - $2.81 Million
-26,814 Reduced 0.28%
9,570,718 $903 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $24.2 Million - $31.6 Million
257,237 Added 2.75%
9,597,532 $971 Million
Q4 2022

Feb 10, 2023
BUY
$106.72 - $127.06 $36.2 Million - $43.1 Million
339,332 Added 3.77%
9,340,295 $1.12 Billion
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $8.88 Million - $10.4 Million
96,489 Added 1.08%
9,000,963 $956 Million
Q2 2022

Aug 12, 2022
BUY
$75.79 - $100.07 $9.63 Million - $12.7 Million
127,016 Added 1.45%
8,904,474 $868 Million
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $763,115 - $998,633
-10,533 Reduced 0.12%
8,777,458 $823 Million
Q4 2021

Feb 14, 2022
SELL
$79.65 - $106.22 $8 Million - $10.7 Million
-100,479 Reduced 1.13%
8,787,991 $748 Million
Q3 2021

Nov 12, 2021
SELL
$86.18 - $99.03 $8.29 Million - $9.52 Million
-96,151 Reduced 1.07%
8,888,470 $852 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $803 Million - $919 Million
8,984,621 New
8,984,621 $874 Million

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.6M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email